comparemela.com

Latest Breaking News On - Azn ln - Page 10 : comparemela.com

AstraZeneca Shares Rise After 2Q Revenue, Earnings Beat Market Views -- Update

By Joe Hoppe AstraZeneca shares rose Friday after the company reported a significant rise in second-quarter revenue and earnings per share, ahead of market.

Joe hoppeArticle normalBiotechnology servicesHealthcare life sciencesFinancial performanceSales figuresShare price movement disruptionsCorporate industrial newsEquity marketsCommodity financial market newsContent typesFactiva filtersC amp ampe exclusion filterC amp ampe industry news filterIwe filterRoutine market financial news

Big Pharma Bets Big on China

Western drugmakers have aligned themselves with Beijing’s health priorities and are tapping local startups for innovative medicines

Clarence leongRolex dela pena zumaDow jones company incRolex delaAll rightsBiotechnology servicesHealthcare life sciencesSpecialized drugs medicationsRegulation government policyContracts ordersNon government contracts ordersLicensing agreementsCorporate industrial newsPolitical general newsSociety communityMedical treatments procedures

Pieris Pharma to Cut 70% of Workforce, Explore Strategic Options

By Ben Glickman Pieris Pharmaceuticals said Tuesday it would cut about 70% of its workforce and explore strategic options after AstraZeneca terminated a.

United statesBen glickmanPieris pharmaceuticalsArticle normalBiotechnology servicesHealthcare life sciencesLabor personnelCorporate industrial newsLay offs redundanciesContent typesFactiva filtersC amp ampe industry news filterAzn lnUk aznIndustrial newsLay offs

FDA Approves First RSV Drug to Protect All Infants From Virus

While the infection often leads to mild, coldlike symptoms, it is the leading cause of hospitalization of infants in the U.S.

Jareds hopkinsDow jones company incAll rightsHealthcare life sciencesRegulation government policyNew products servicesProduct service approvalsCorporate industrial newsProducts servicesPolitical general newsDemographic healthInfant child teenage healthContent typesFactiva filtersC ampe industry news filterWsj pro com

CDC Advisors Give Tepid Endorsement of GSK, Pfizer RSV Vaccines What to Know

A key committee backed a policy saying adults 65 and older "may receive" the shots, rather than one saying the injections "are recommended."

United statesJosh nathan kazisLuis jodarChris shibutaniKsenia kuleshova bloombergEmma walmsleyRochelle walenskyGoldman sachsCenters for diseaseDrug administrationAdvisory committee on immunization practicesDisease controlAdvisory committeeImmunization practicesBavarian nordicRetail wholesale

vimarsana © 2020. All Rights Reserved.